COX-2 Inhibitors May Improve Cancer Immunotherapy Response – Immuno-Oncology News
|
COX-2 Inhibitors May Improve Cancer Immunotherapy Response
Immuno-Oncology News “Our studies provide a clear rationale to test, in the clinics, combinations of anti-PD1 immunotherapy and COX-2 inhibitors,” Van den Eynde said. “This should be straightforward given the fact that both anti-PD1 and COX-2 inhibitors are already … |
